BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11559315)

  • 1. Cognitive deficits associated with a recently reported familial neurodegenerative disease: familial encephalopathy with neuroserpin inclusion bodies.
    Bradshaw CB; Davis RL; Shrimpton AE; Holohan PD; Rea CB; Fieglin D; Kent P; Collins GH
    Arch Neurol; 2001 Sep; 58(9):1429-34. PubMed ID: 11559315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited Unfolded Protein Response and Inflammation in Neuroserpinopathy.
    López-González I; Pérez-Mediavilla A; Zamarbide M; Carmona M; Torrejón Escribano B; Glatzel M; Galliciotti G; Ferrer I
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):121-33. PubMed ID: 26733586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontal deficits and atrophy in a patient with familial encephalopathy with neuroserpin inclusion bodies detected by single-case voxel-based morphometry: a case report.
    Handa H; Sugiyama A; Kaname T; Shigemoto Y; Sato N; Hirano S; Nakagawa Y; Uzawa A; Aotsuka A; Kuwabara S
    BMC Neurol; 2024 Jan; 24(1):9. PubMed ID: 38166833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial encephalopathy with neuroserpin inclusion bodies.
    Davis RL; Holohan PD; Shrimpton AE; Tatum AH; Daucher J; Collins GH; Todd R; Bradshaw C; Kent P; Feiglin D; Rosenbaum A; Yerby MS; Shaw CM; Lacbawan F; Lawrence DA
    Am J Pathol; 1999 Dec; 155(6):1901-13. PubMed ID: 10595921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and neuropathologic study of a French family with a mutation in the neuroserpin gene.
    Gourfinkel-An I; Duyckaerts C; Camuzat A; Meyrignac C; Sonderegger P; Baulac M; Brice A
    Neurology; 2007 Jul; 69(1):79-83. PubMed ID: 17606885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lectin OS-9 delivers mutant neuroserpin to endoplasmic reticulum associated degradation in familial encephalopathy with neuroserpin inclusion bodies.
    Schipanski A; Oberhauser F; Neumann M; Lange S; Szalay B; Krasemann S; van Leeuwen FW; Galliciotti G; Glatzel M
    Neurobiol Aging; 2014 Oct; 35(10):2394-403. PubMed ID: 24795221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant Neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro.
    Belorgey D; Crowther DC; Mahadeva R; Lomas DA
    J Biol Chem; 2002 May; 277(19):17367-73. PubMed ID: 11880376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive myoclonus epilepsy associated with neuroserpin inclusion bodies (neuroserpinosis).
    Roussel BD; Lomas DA; Crowther DC
    Epileptic Disord; 2016 Sep; 18(S2):103-110. PubMed ID: 27618835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of mutant neuroserpin precedes development of clinical symptoms in familial encephalopathy with neuroserpin inclusion bodies.
    Galliciotti G; Glatzel M; Kinter J; Kozlov SV; Cinelli P; Rülicke T; Sonderegger P
    Am J Pathol; 2007 Apr; 170(4):1305-13. PubMed ID: 17392169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial dementia caused by polymerization of mutant neuroserpin.
    Davis RL; Shrimpton AE; Holohan PD; Bradshaw C; Feiglin D; Collins GH; Sonderegger P; Kinter J; Becker LM; Lacbawan F; Krasnewich D; Muenke M; Lawrence DA; Yerby MS; Shaw CM; Gooptu B; Elliott PR; Finch JT; Carrell RW; Lomas DA
    Nature; 1999 Sep; 401(6751):376-9. PubMed ID: 10517635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serpinopathies studying serpin polymerization in vivo.
    Irving JA; Ekeowa UI; Belorgey D; Haq I; Gooptu B; Miranda E; Pérez J; Roussel BD; Ordóñez A; Dalton LE; Thomas SE; Marciniak SJ; Parfrey H; Chilvers ER; Teckman JH; Alam S; Mahadeva R; Rashid ST; Vallier L; Lomas DA
    Methods Enzymol; 2011; 501():421-66. PubMed ID: 22078544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G392E neuroserpin causing the dementia FENIB is secreted from cells but is not synaptotoxic.
    Ingwersen T; Linnenberg C; D'Acunto E; Temori S; Paolucci I; Wasilewski D; Mohammadi B; Kirchmair J; Glen RC; Miranda E; Glatzel M; Galliciotti G
    Sci Rep; 2021 Apr; 11(1):8766. PubMed ID: 33888787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB.
    Belorgey D; Sharp LK; Crowther DC; Onda M; Johansson J; Lomas DA
    Eur J Biochem; 2004 Aug; 271(16):3360-7. PubMed ID: 15291813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroserpin: a serpin to think about.
    Miranda E; Lomas DA
    Cell Mol Life Sci; 2006 Mar; 63(6):709-22. PubMed ID: 16465451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent S49P neuroserpin forms polymers in the dementia familial encephalopathy with neuroserpin inclusion bodies.
    Onda M; Belorgey D; Sharp LK; Lomas DA
    J Biol Chem; 2005 Apr; 280(14):13735-41. PubMed ID: 15664988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Japanese family with mutation in the proteinase inhibitor 12 L47P gene: A case report.
    Amano-Takeshige H; Oyama G; Kanai K; Miyagawa T; Mitsui J; Ugawa Y; Tsuji S; Hattori N
    J Neurol Sci; 2018 Jan; 384():126-128. PubMed ID: 29249370
    [No Abstract]   [Full Text] [Related]  

  • 17. Sterol metabolism regulates neuroserpin polymer degradation in the absence of the unfolded protein response in the dementia FENIB.
    Roussel BD; Newton TM; Malzer E; Simecek N; Haq I; Thomas SE; Burr ML; Lehner PJ; Crowther DC; Marciniak SJ; Lomas DA
    Hum Mol Genet; 2013 Nov; 22(22):4616-26. PubMed ID: 23814041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of SERPINI1 pathogenic variants in familial encephalopathy with neuroserpin inclusion bodies: A case report and literature review.
    Yang X; Fang Z; Yan L; He X; Luo H; Han Z; Gui J; Cheng M; Jiang L
    Seizure; 2022 Dec; 103():137-147. PubMed ID: 36417830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between conformational mutations in neuroserpin and onset and severity of dementia.
    Davis RL; Shrimpton AE; Carrell RW; Lomas DA; Gerhard L; Baumann B; Lawrence DA; Yepes M; Kim TS; Ghetti B; Piccardo P; Takao M; Lacbawan F; Muenke M; Sifers RN; Bradshaw CB; Kent PF; Collins GH; Larocca D; Holohan PD
    Lancet; 2002 Jun; 359(9325):2242-7. PubMed ID: 12103288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of serpin polymers in vitro and in vivo.
    Belorgey D; Irving JA; Ekeowa UI; Freeke J; Roussel BD; Miranda E; Pérez J; Robinson CV; Marciniak SJ; Crowther DC; Michel CH; Lomas DA
    Methods; 2011 Mar; 53(3):255-66. PubMed ID: 21115126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.